Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1999 Mar;26(4):527-30.

[Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis]

[Article in Japanese]
Y Nishioka  1 , O Kitada, T Meguro, K Aragane, T Tanimukai, H Nakamura, H Nakahama, T Matsuyama, M Sugita, T Yano, Y Takenaka, Y Takamitsu
Affiliations
  • PMID: 10097751
Case Reports

[Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis]

[Article in Japanese]
Y Nishioka et al. Gan To Kagaku Ryoho. 1999 Mar.

Abstract

A 61-year-old man with chronic renal failure caused by polycystic kidney disease requiring hemodialysis three times weekly developed small cell carcinoma of the lung. The patient received combination chemotherapy with nedaplatin (50 mg) and etoposide (50 mg). Blood levels were monitored, showing that nedaplatin was more dialyzable than cisplatin. The patient achieved a complete response. These results suggest that nedaplatin-etoposide combination chemotherapy may be safer than cisplatin-containing regimen for patients with chronic renal failure hemodialysis and that a satisfactory response can be expected.

PubMed Disclaimer

MeSH terms

LinkOut - more resources